LFST Net Income Growth
413.29%TTM
Period ending:
LFST TTM Net Income YoY %%
802.91%-3223.12%
2021-12-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
LFST net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 19 observations from Dec 31, 2021 to Jun 30, 2026.
| Period ending | Net Income Growth |
|---|---|
| 413.2933% | |
| 165.0925% | |
| 116.8219% | |
| 90.4324% | |
| 89.298% | |
| 79.4145% | |
| 69.1601% | |
| 49.3028% | |
| 8.1064% | |
| 7.6601% | |
| 13.5932% | |
| 32.1296% | |
| 54.3221% | |
| 48.0444% | |
| 29.8287% | |
| -35.3188% | |
| -310.9088% | |
| -1,554.7118% | |
| -2,833.5084% |
Compare net income growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) net income growth
- Ensign Group Inc (ENSG) net income growth
- Krystal Biotech Inc (KRYS) net income growth
- Protagonist Therapeutics Inc (PTGX) net income growth
- Tg Therapeutics Inc (TGTX) net income growth
- Healthequity Inc (HQY) net income growth
- Pacs Group Inc (PACS) net income growth
- Alkermes (ALKS) net income growth
Compare all covered stocks by net income growth →
All LFST financial metrics · LFST stock overview · How to interpret financial metrics
